CXCR	C-X-C motif chemokine receptor
CXCL	C-X-C motif chemokine ligand
BME	Bone marrow microenvironment
TME	Tumor microenvironment
MDS	Myelodysplastic syndrome
AL	Acute leukemia
AML	Acute Myeloid Leukemia
ALL	Acute lymphoblastic leukemia
CML	Chronic myeloid leukemia
CLL	Chronic lymphocytic leukemia
ML	Malignant lymphoma
CLL/SLL	Chronic lymphocytic leukemia/small lymphocytic lymphoma
MM	Multiple myeloma
MPN	Myeloproliferative neoplasm
HL	Hodgkin lymphoma
NHL	Non-Hodgkin lymphoma
MDSCs	Myeloid-derived suppressor cells
TANs	Tumor-associated neutrophils
TAMs	Tumor-associated macrophages
Tregs	Regulatory T cells
NK cells	Natural killer cells
PD1	Programmed death receptor 1
PI3K	Phosphatidylinositol 3-kinase
AKT	Protein kinase B
NF-κB	Nuclear factor kappa-B
HSCs	Hematopoietic stem cells
CR	Complete response
DFS	Disease-free survival rate
CAR-T	Chimeric antigen receptor T cells
PLC	Phospholipase C
PBMCs	Peripheral blood mononuclear cells
ACT	Adoptive cell transfer therapy
STAT3	Signal transducer and activator of transcription 3
TKIs	Tyrosine kinase inhibitors
Ph	Philadelphia chromosome
mTOR	Mammalian target of rapamycin
MRD	Minimal or molecular residual disease
LSCs	Leukemia stem cells
TNF-α	Tumor necrosis factor α
BMSCs	Bone marrow stromal cells
ERK	Extracellular signal-regulated kinase
HTLV-1	Host–human T-cell leukemia virus type 1
ATLL	Adult T-cell leukemia/lymphoma
PVL	Proviral load
MZL	Marginal zone lymphoma
BLR1	Burkitt lymphoma receptor 1
LPL	Lymphoplasmacytic lymphoma
WM	Waldenström macroglobulinemia
PLK1	Polo-like Kinase 1
FOXM1	Forkhead box protein M1
JNK	Jun N-terminal kinase
DLBCL	Diffuse large B-cell lymphoma
TEM	Transendothelial migration